Technology | May 12, 2008

ALTRUA Family of Pacemakers Treat Bradycardia


Boston Scientific's ALTRUA family of pacemakers is the first Boston Scientific-branded pacemaker to treat bradycardia.

The ALTRUA pacemaker provides physicians with a number of diagnostic and therapeutic capabilities designed to enable them to tailor the therapy to specific patient requirements. Some of the main features include multiple atrial ventricular (AV) delay programming options; minute ventilation (MV) blended sensor; ventricular rate regulation (VRR); and automatic capture for ventricular pulse management. The device checks every heart beat to see if the lower chambers of the heart contract in response to the delivered pulse. If no contraction is detected, a backup pace with more energy is delivered.


Related Content

News | Pacemakers

August 21, 2023 — The first implant in Europe of Biotronik’s latest pacemaker and CRT-P generation was conducted in ...

Home August 21, 2023
Home
News | Pacemakers

July 6, 2023 — BIOTRONIK announced U.S. Food and Drug Administration (FDA) approval of its portfolio of Amvia Edge ...

Home July 06, 2023
Home
News | Pacemakers

July 5, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the AVEIR dual chamber (DR ...

Home July 05, 2023
Home
News | Pacemakers

June 1, 2023 — Every year more than one million people receive a pacemaker. Until now, leadless versions were only ...

Home June 01, 2023
Home
News | Pacemakers

May 25, 2023 — Abbott announced late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device ...

Home May 25, 2023
Home
News | Pacemakers

May 12, 2023 — Biotronik, a leading global medical technology company with 60 years of experience in developing trusted ...

Home May 12, 2023
Home
News | Pacemakers

May 1, 2023 — Medtronic plc, a global leader in healthcare technology, announced it has received U.S. Food and Drug ...

Home May 01, 2023
Home
News | Pacemakers

December 12, 2022 — The global pacemakers market is set to grow at a compound annual growth rate (CAGR) of 5.4% between ...

Home December 12, 2022
Home
News | Pacemakers

June 9, 2022 — Holes help make sponges and English muffins useful (and, in the case of the latter, delicious). Without ...

Home June 09, 2022
Home
News | Pacemakers

April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber ...

Home April 05, 2022
Home
Subscribe Now